Vis enkel innførsel

dc.contributor.authorBeavo, Joseph A.en_US
dc.contributor.authorBos, Johannes L.en_US
dc.contributor.authorButt, Elkeen_US
dc.contributor.authorDøskeland, Stein Oveen_US
dc.contributor.authorGenieser, Hans-Gottfrieden_US
dc.contributor.authorHinds, Thomas R.en_US
dc.contributor.authorPoppe, Heikoen_US
dc.contributor.authorRehmann, Holgeren_US
dc.contributor.authorRybalkin, Sergei D.en_US
dc.contributor.authorSchwede, Franken_US
dc.contributor.authorTang, Xiao-Boen_US
dc.date.accessioned2008-03-28T11:51:01Z
dc.date.available2008-03-28T11:51:01Z
dc.date.issued2007-07-25eng
dc.PublishedBMC Pharmacology, 7(Suppl 1):S25en
dc.identifier.urihttps://hdl.handle.net/1956/2630
dc.descriptionOral presentation from 3rd International Conference on cGMP Generators, Effectors and Therapeutic Implications Dresden, Germany. 15–17 June 2007en
dc.language.isoengeng
dc.publisherBioMed Centraleng
dc.titleSpecificity of commonly used cyclic nucleotides with PKA, PKG and Epac-implementing microcalorimetry to determine PDE activitiesen_US
dc.typeConference object
dc.rights.holderCopyright 2007 Beavo et al; licensee BioMed Central Ltd.
dc.identifier.doihttps://doi.org/10.1186/1471-2210-7-s1-s25


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel